Relapsing polychondritis-like ear disease responding to etanercept in two patients with psoriasis and psoriatic arthritis - 10/08/11

| Funding sources: Both patients are parts of phase IV clinical trials of etanercept and the drugs were provided by Wyeth Pharmaceuticals, Collegeville, PA. |
|
| Conflicts of interest: Dr Tsai has conducted clinical trials for etanercept and received honoraria for serving as a consultant for Wyeth Pharmaceuticals. Dr Lee has no conflicts of interest to disclose. |
Vol 64 - N° 5
P. 1006-1007 - maggio 2011 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
